Serratus Plane Block After Minimally Invasive Mitral Valve Repair
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
Patients undergoing minimally invasive mitral valve reconstruction via small thoracotomy are
randomized into two groups.
The intervention group receives serratus anterior plane block after minimally invasive
mitral-valve reconstruction, following 48h infusion with ropivacaine 2% continually.
The control group receives a placebo pump without infusion. Primary endpoints are perceived
pain using a numeric pain rating scale and opioid consumption during the hospital stay.